Dr. Anju Grover, MD
What this data tells you about Dr. Grover
Dr. Anju Grover is an internal medicine specialist in Melbourne, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Grover performed 2,031 Medicare services across 1,344 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grover received a total of $7,341 from 41 pharmaceutical and/or device companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grover is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 93916 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 469 | $86 | $270 |
| Office visit, established patient (20-29 min) | 390 | $63 | $183 |
| Annual wellness visit, follow-up | 171 | $128 | $291 |
| Annual depression screening | 170 | $18 | $45 |
| Drug injection, under skin or into muscle | 116 | $10 | $63 |
| Flu vaccine administration | 107 | $30 | $63 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 103 | $33 | $70 |
| Ceftriaxone antibiotic injection | 86 | $0 | $58 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 60 | $1 | $63 |
| Advance care planning consultation, first 30 min | 57 | $82 | $208 |
| Electrocardiogram (EKG), 12-lead | 42 | $10 | $43 |
| Transitional care management services for problem of at least moderate complexity | 40 | $157 | $409 |
| Injection, methylprednisolone acetate, 40 mg | 34 | $5 | $30 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 30 | $164 | $430 |
| New patient office visit (45-59 min) | 25 | $102 | $415 |
| Automated urinalysis | 21 | $2 | $8 |
| Urinalysis, manual | 20 | $3 | $9 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 20 | $40 | $135 |
| Pneumonia vaccine administration | 16 | $26 | $63 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 15 | $153 | $418 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 14 | $4 | $43 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $239 | $397 |
| Test to measure expiratory airflow and volume | 12 | $16 | $88 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Grover is a clinical cardiology specialist, with above-average Medicare volume (top 21% in FL), with low-engagement industry engagement in the top 9% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Grover experienced with office visit, established patient (30-39 min)?
Does Dr. Grover receive payments from pharmaceutical companies?
How do Dr. Grover's costs compare to other internal medicine physicians in Melbourne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology